• First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple cancers

    5 monthes ago - By ScienceDaily

    A phase I, first-in-human study reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary and papillary thyroid, non-small cell lung, colorectal and bile duct cancers, which have been historically difficult to treat.
    Read more ...

     

  • Study of promising targeted drug delivery scaffold

    5 monthes ago - By ScienceDaily

    Researchers have studied a self-assembling virus shell to learn how to change its physical properties so it can be designed for use in detecting diseases and targeted drug delivery and vaccinations.
    Read more ...

     

  • New Method Aids Study of Promising Targeted Drug Delivery Scaffold

    New Method Aids Study of Promising Targeted Drug Delivery Scaffold

    5 monthes ago - By Medindia Health

    A new way to manipulate a virus shell that self-assembles from proteins and holds promise as a carrier for disease detection, drug delivery, and vaccinations developed.
    Read more ...